4//SEC Filing
Leamon Christopher P 4
Accession 0001209191-21-062419
CIK 0001805890other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 4:37 PM ET
Size
5.5 KB
Accession
0001209191-21-062419
Insider Transaction Report
Form 4
Leamon Christopher P
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-01+218,000→ 218,000 totalExercise: $7.09Exp: 2031-11-01→ Common Stock (218,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest and become exercisable on the first anniversary of the grant date and the remainder shall vest and become exercisable in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001509415
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 4:37 PM ET
- Size
- 5.5 KB